Bispecific Antibody Deal Benchmarks
Market Analysis
Bispecific antibodies represent one of the most actively transacted modalities in oncology licensing. Phase 2 bispecific deals achieve a median total deal value of $2.2B, with upfront payments between $194M and $492M. The modality's versatility across T-cell engagement, dual checkpoint blockade, and receptor crosslinking drives strong licensee interest.
Milestone allocations in bispecific transactions reflect a balanced risk profile. Development milestones average $466M, while regulatory and commercial milestones contribute $745M and $652M, respectively. The overall deal recommendation splits at approximately 16% upfront and 84% milestones.
Royalty rates for bispecific licensing deals range from 12.9% to 21.1% at the base tier, with escalation to 25.1% on high-volume sales. Bispecifics with novel mechanisms (e.g., tumor-conditional activation or half-life extension) tend to attract premium terms relative to conventional T-cell engagers.
Full Benchmark Analysis
Complete deal term ranges, comparable transactions, and negotiation insights.
Start 7-Day Free Trial$299/mo after trial · Cancel anytime
Customize these benchmarks for your asset
Adjust phase, modality, competitive position, and 10+ other parameters.
Frequently Asked Questions
What is the median total deal value for bispecific antibody licensing?
How do bispecific deal terms compare to standard monoclonal antibodies?
What factors influence bispecific antibody deal valuations?
What royalty rates are typical for bispecific deals?
Full Benchmark Analysis
Complete deal term ranges, comparable transactions, and negotiation insights.
Start 7-Day Free Trial$299/mo after trial · Cancel anytime
Ready to Calculate Your Deal Terms?
Get instant, customized benchmarks based on real market data from 1,600+ biopharma licensing deals.
Start CalculatingNeed the full deal landscape?
The Deal Intelligence Brief covers every modality and deal structure for this indication — 52 deal calculations, AI strategic narrative, comparable transactions, partner matching, and white-label branding. Delivered in 24 hours.